The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment

Overview

Journal Cell Transplant

Specialties Cell Biology
General Surgery

Date 2023 Dec 23

PMID 38135917

Authors

Luxiao Zhang

Affiliations

Soon will be listed here.

Abstract

The role of mesenchymal stem cells (MSCs) in the breast tumor microenvironment (TME) is significant and multifaceted. MSCs are recruited to breast tumor sites through molecular signals released by tumor sites. Once in the TME, MSCs undergo polarization and interact with various cell populations, including immune cells, cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs), and breast cancer cells. In most cases, MSCs play roles in breast cancer therapeutic resistance, but there is also evidence that indicates their abilities to sensitize cancer cells to chemotherapy and radiotherapy. MSCs possess inherent regenerative and homing properties, making them attractive candidates for cell-based therapies. Therefore, MSCs can be engineered to express therapeutic molecules or deliver anti-cancer agents directly to tumor sites. Unraveling the intricate relationship between MSCs and the breast TME has the potential to uncover novel therapeutic targets and advance our understanding of breast cancer biology.

Citing Articles

Advancements in the Application of scRNA-Seq in Breast Research: A Review.

Zhang Z, Ma X, La Y, Guo X, Chu M, Bao P Int J Mol Sci. 2025; 25(24.

PMID: 39769466 PMC: 11677372. DOI: 10.3390/ijms252413706.

Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro.

Basmaeil Y, Subayyil A, Kulayb H, Kondkar A, Alrodayyan M, Khatlani T Cells. 2025; 13(24.

PMID: 39768220 PMC: 11674051. DOI: 10.3390/cells13242131.

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.

Epigenetic and Immune Mechanisms Linking Breastfeeding to Lower Breast Cancer Rates.

Surdacka L, Jakubas A, Jagiello J, Danilowska K, Picheta N, Gil-Kulik P Med Sci Monit. 2024; 30:e945451.

PMID: 39497379 PMC: 11549897. DOI: 10.12659/MSM.945451.

Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells.

Garza Trevino E, Quiroz Reyes A, Delgado Gonzalez P, Rojas Murillo J, Islas J, Alonso S Int J Mol Sci. 2024; 25(14).

PMID: 39063032 PMC: 11276748. DOI: 10.3390/ijms25147791.

References

Zhang L, Zheng B, Guo R, Miao Y, Li B . Bone marrow mesenchymal stem cell-mediated ultrasmall gold nanoclusters and hNIS gene synergize radiotherapy for breast cancer. J Mater Chem B. 2021; 9(12):2866-2876. DOI: 10.1039/d1tb00186h. View

Ma X, Chen J, Liu J, Xu B, Liang X, Yang X . IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133 /CD44 Colon cancer stem cells. J Cell Physiol. 2020; 236(4):3114-3128. DOI: 10.1002/jcp.30080. View

Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P . Breast cancer. Nat Rev Dis Primers. 2019; 5(1):66. DOI: 10.1038/s41572-019-0111-2. View

Zhang T, Lee Y, Rui Y, Cheng T, Jiang X, Li G . Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors. Stem Cell Res Ther. 2013; 4(3):70. PMC: 3707041. DOI: 10.1186/scrt221. View

Harrell C, Volarevic V, Djonov V, Volarevic A . Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases. Int J Mol Sci. 2022; 23(9). PMC: 9105552. DOI: 10.3390/ijms23094487. View

Hinshaw D, Shevde L . The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019; 79(18):4557-4566. PMC: 6744958. DOI: 10.1158/0008-5472.CAN-18-3962. View

Wopereis S, Walter L, Vieira D, Ribeiro A, Fernandes B, Wilkens R . Evaluation of ER, PR and HER2 markers by flow cytometry for breast cancer diagnosis and prognosis. Clin Chim Acta. 2021; 523:504-512. DOI: 10.1016/j.cca.2021.11.005. View

Gramann A, Frantz W, Dresser K, Gomes C, Lian C, Deng A . BMP Signaling Promotes Neural Crest Identity and Accelerates Melanoma Onset. J Invest Dermatol. 2021; 141(8):2067-2070.e1. DOI: 10.1016/j.jid.2021.01.021. View

Hung S, Yang M, Tseng K, Lee O . Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant. 2012; 22(10):1869-82. DOI: 10.3727/096368912X657954. View

10.

Li A, Muenst S, Hoffman J, Starck L, Sarem M, Fischer A . Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model. Commun Biol. 2022; 5(1):1303. PMC: 9701219. DOI: 10.1038/s42003-022-04236-5. View

11.

McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S . Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest. 2011; 121(8):3206-19. PMC: 3148732. DOI: 10.1172/JCI45273. View

12.

Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J . Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling. Cancer Manag Res. 2020; 12:8733-8744. PMC: 7519869. DOI: 10.2147/CMAR.S270200. View

13.

Lin S, Yang J, Everett A, Clevenger C, Koneru M, Mishra P . The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res. 2008; 314(17):3107-17. PMC: 2606107. DOI: 10.1016/j.yexcr.2008.07.028. View

14.

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

15.

Lu Y, Yang Y, Liu Y, Hao Y, Zhang Y, Hu Y . Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer. Biochem Biophys Res Commun. 2017; 494(3-4):719-727. DOI: 10.1016/j.bbrc.2017.10.118. View

16.

Plava J, Cihova M, Burikova M, Bohac M, Adamkov M, Drahosova S . Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy. Cells. 2020; 9(2). PMC: 7072834. DOI: 10.3390/cells9020480. View

17.

Bajetto A, Pattarozzi A, Corsaro A, Barbieri F, Daga A, Bosio A . Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors. Front Cell Neurosci. 2017; 11:312. PMC: 5645520. DOI: 10.3389/fncel.2017.00312. View

18.

Matuskova M, Kozovska Z, Toro L, Durinikova E, Tyciakova S, Cierna Z . Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. J Exp Clin Cancer Res. 2015; 34:33. PMC: 4431639. DOI: 10.1186/s13046-015-0149-2. View

19.

Hu X, Zhou Y, Dong K, Sun Z, Zhao D, Wang W . Programming of the development of tumor-promoting neutrophils by mesenchymal stromal cells. Cell Physiol Biochem. 2014; 33(6):1802-14. DOI: 10.1159/000362959. View

20.

Beerts C, Pauwelyn G, Depuydt E, Xu Y, Saunders J, Peremans K . Homing of radiolabelled xenogeneic equine peripheral blood-derived MSCs towards a joint lesion in a dog. Front Vet Sci. 2022; 9:1035175. PMC: 9729935. DOI: 10.3389/fvets.2022.1035175. View